Irritable bowel syndrome Survey in gastroenterological adult outpatients in China

Trial Identifier: D1844R00004
Sponsor: AstraZeneca
NCTID:: NCT02955316
Start Date: February 2017
Primary Completion Date: September 2017

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China, Hubei Wuhan, Hubei, China